Home › Therapeutic areas › Neurology › Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (6 companies)
Companies with an active program in Amyotrophic Lateral Sclerosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | MetabolicNeurology Rare | 1 | Phase 3 | 5 |
| ANNX | Annexon, Inc. | HematologyNeurologyOphthalmologyRenal Rare | 1 | NDA Submitted | 6 |
| CRVO | CervoMed Inc. | Neurology Rare | 1 | Phase 2 | 5 |
| CLNN | Clene Inc. | Neurology Rare | 1 | NDA Submitted | 5 |
| QURE | uniQure N.V. | HematologyMetabolicNeurology Rare | 1 | Approved | 6 |
| VYGR | Voyager Therapeutics, Inc. | MetabolicNeurology Rare | 1 | Phase 1 | 7 |
No companies match.